Effects of enzyme inducing antiepileptic drugs on lipid and bone metabolism

Masako Watanabe, Yoshimi Morita, Kokichi Morimoto, Yutaka Watanabe

研究成果: Article査読

抄録

The effects of enzyme inducing antiepileptic drugs (EIAED) on laboratory test values were studied in 277 patients with epilepsy treated with antiepileptic drugs (AED). The patients were divided into an EIAED group and a non-EIAED group. Total cholesterol (TC) and alkaline phosphatase (ALP) were significantly higher (p<0.001 for both) and white blood cell count was significantly lower (p<0.01) in the EIAED group than in the non-EIAED group. In all subjects, ALP was significantly higher in males (p<0.05), and ALP increased with age in females. Especially, ALP was significantly higher in the EIAED group than in the non-EIAED group irrespective of gender (males: p<0.001, females: p<0.001). The proportion of patients with abnormal level of bone-specific isoform of ALP (bALP) was significantly high in the EIAED group than in the non-EIAED group (12% versus 3%, p=0.015). These findings suggest that the enzyme-inducing effects of EIAED may impact on both lipid and bone metabolism. Therefore, regular monitoring and dose adjustment have to be considered.

本文言語English
ページ(範囲)610-618
ページ数9
ジャーナルJournal of the Japan Epilepsy Society
34
3
DOI
出版ステータスPublished - 2017

ASJC Scopus subject areas

  • 神経学
  • 臨床神経学

フィンガープリント

「Effects of enzyme inducing antiepileptic drugs on lipid and bone metabolism」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル